Subsidiary enters Asset Transfer Agreement for dialysis centre assets in the Philippines
Nephrocare's Philippines step-down wholly-owned subsidiary has entered into an Asset Transfer Agreement with JCM Summit Health Inc. for identified assets of a dialysis centre in Quezon City, Philippines.
By ScoutQuest · · 2 min read
- Agreement Date
- Asset Transfer Agreement dated October 27, 2026
- Asset Location
- dialysis centre at Don Mariano Marcos Avenue, Quezon City, Philippines
- Materiality
- value of the transaction exceeds the materiality threshold; consideration confidential
What was announced
Nephrocare Health Services, Philippines Inc., described as an overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited, has entered into an Asset Transfer Agreement (ATA) dated October 27, 2026 with JCM Summit Health Inc.
The agreement is for the acquisition of identified assets relating to a dialysis centre located at Don Mariano Marcos Avenue, Quezon City, Philippines. The transaction is in accordance with, and subject to, the terms and conditions set out in the ATA.
Who is buying and who is selling
- Purchaser: Nephrocare Health Services, Philippines Inc., an overseas step-down wholly-owned subsidiary of the company.
- Seller: JCM Summit Health Inc. The company states that the seller is not related to the promoter, promoter group or group companies in any manner.
Size of the deal
The company states that the value of the transaction exceeds the materiality threshold determined in accordance with the company's Policy for Determination of Materiality of Events/Information.
The consideration payable under the ATA is not being disclosed, as the company treats it as confidential and commercially sensitive information, and says its disclosure may adversely affect the company's competitive position in the market.
Other terms disclosed
- No special rights have been granted under the ATA, including rights such as appointing directors, a first right to share subscription in case of an issue of shares, or the right to restrict a change in capital structure.
- The transaction does not fall within related party transactions.
- The shareholding, if any, in the entity with whom the agreement is executed is marked not applicable, and the issuance of shares to the parties is also marked not applicable.
What this means for a retail investor
This is an asset purchase made one layer below the listed company, through an overseas step-down subsidiary, and it relates to a dialysis centre in the Philippines.
The company's own materiality test says the value exceeds the threshold, which is why it is being disclosed as a material event. The rupee size of the consideration is held back as confidential, so the price being paid for the assets cannot be weighed from this disclosure alone.
Nothing in the update points to a fresh issue of shares, a loan arrangement, or any change in the listed company's share capital. The counterparty is an unrelated party, so this is not a related party deal.
Also from Nephrocare Health Services
Uzbek court declares invalid a ₹14.79 crore tax demand on overseas subsidiary
2 Nov 2026
NephroPlus to hold Q2FY27 earnings call on November 4, 2026 at 11:00 AM IST
21 Oct 2026
Board meeting on November 3, 2026 to consider and approve September quarter and half year results
12 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.